Anticancer drug development at the US National Cancer Institute
β Scribed by Chris H. Takimoto
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 237 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The development of informative composite circulating biomarkers predicting cancer presence or therapy response is clinically attractive but optimal approaches to modeling are as yet unclear. This study investigated multidimensional relationships within an example panel of serum insulinβ
## Abstract ## Background. The literature suggests that the natural history of squamous cell carcinoma of the oral cavity may vary and the prognosis is different in patients from developing and developed nations. The objective of this study was to compare the clinical presentation, management, and